PPE significantly (p < 0.05) inhibited the CaOx crystallization in a concentration-dependent manner.
PPE significantly (p < 0.05) prevented this cellular injury, reduced the LDH release and improved the cell viability to 92.45%.
No differences among PPE-score (p = 0.33) and influenza vaccination status (p = 0.28) regarding acquiring acute respiratory symptoms were found.
Adherence differed between firemen (mean PPE-score: 6.6) and government workers (mean PPE-score: 4.5; p = 0.006).
A similar, statistically significant trend, was found to be true for IL-17 production in response to the PPE family members Rv0978c (p = 0.003, difference between groups 1 and 3) and Rv1917c (p = 0.008, difference between groups 1 and 3).
Following 6-OHDA, PPT mRNA levels were depressed 60 66% across three subregions of the A-STR and 52 59% across two subregions of the P-STR, while PPE mRNA expression was elevated in both the A-STR (50 62%) and P-STR (55 82%).
Patients who achieved an objective response or at least SD had PPE more frequently (26% vs 10%, P = 0.016).
In addition, blockage of the JNK and p-38 MAPK pathways (PPE SP and PPE SB) and silencing of PlGF (PPE Pl-si) attenuated the levels of PPE-induced pulmonary apoptosis and the air space enlargement in PPE-treated mice.
Vulnerable patients (i.e. poor SRH and functional impairment) reported significantly less positive care experiences than did non-vulnerable patients (mean PPE-15 score 75 vs 85; p < 0.0001).
Fifty percent of those who could read easily used more than 2 PPE compared to 26% who did not, (p < 0.01).
